BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Prognosis
17 results:

  • 1. Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing.
    Yang J; Liu K; Yang L; Ji J; Qin J; Deng H; Wang Z
    Front Immunol; 2023; 14():1174762. PubMed ID: 37287976
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immune infiltration landscape on prognosis and therapeutic response and relevant epigenetic and transcriptomic mechanisms in lung adenocarcinoma.
    Zhang L; Jiang B; Lan Z; Yang C; Yao Y; Lin J; Wei Q
    Front Immunol; 2022; 13():983570. PubMed ID: 36275753
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. YAP derived circ-LECRC functions as a "brake signal" to suppress hyperactivation of oncogenic YAP signalling in colorectal cancer.
    An Y; Xu B; Yan G; Wang N; Yang Z; Sun M
    Cancer Lett; 2022 Apr; 532():215589. PubMed ID: 35131381
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. LINC00852 is associated with poor prognosis in non-small cell lung cancer patients and its inhibition suppresses cancer cell proliferation and chemoresistance via the hsa-miR-145-5p/klf4 axis.
    Tuo Z; Liang L; Zhou R
    J Gene Med; 2021 Dec; 23(12):e3384. PubMed ID: 34342374
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
    Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
    Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor.
    Ouyang L; Yan B; Liu Y; Mao C; Wang M; Liu N; Wang Z; Liu S; Shi Y; Chen L; Wang X; Cheng Y; Cao Y; Xiao D; Zhang L; Liu S; Tao Y
    Signal Transduct Target Ther; 2020 Jun; 5(1):78. PubMed ID: 32546741
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
    Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
    Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The deubiquitinase USP10 regulates klf4 stability and suppresses lung tumorigenesis.
    Wang X; Xia S; Li H; Wang X; Li C; Chao Y; Zhang L; Han C
    Cell Death Differ; 2020 Jun; 27(6):1747-1764. PubMed ID: 31748695
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ATXN3 promotes breast cancer metastasis by deubiquitinating klf4.
    Zou H; Chen H; Zhou Z; Wan Y; Liu Z
    Cancer Lett; 2019 Dec; 467():19-28. PubMed ID: 31563563
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Subcellular localization of klf4 in non-small cell lung cancer and its clinical significance.
    Liu M; Li X; Peng KZ; Gao T; Cui Y; Ma N; Zhou Y; Hou G
    Biomed Pharmacother; 2018 Mar; 99():480-485. PubMed ID: 29665649
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. miR-25 enhances cell migration and invasion in non-small-cell lung cancer cells via ERK signaling pathway by inhibiting klf4.
    Ding X; Zhong T; Jiang L; Huang J; Xia Y; Hu R
    Mol Med Rep; 2018 May; 17(5):7005-7016. PubMed ID: 29568911
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
    Wang Y; Zhou Y; Tao F; Chai S; Xu X; Yang Y; Yang Y; Xu H; Wang K
    Cancer Lett; 2017 Aug; 401():53-62. PubMed ID: 28456659
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. miR-103 Promotes Proliferation and Metastasis by Targeting klf4 in Gastric cancer.
    Zheng J; Liu Y; Qiao Y; Zhang L; Lu S
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28445396
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. klf4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth.
    Hu W; Jia Y; Xiao X; Lv K; Chen Y; Wang L; Luo X; Liu T; Li W; Li Y; Zhang C; Yu Z; Huang W; Sun B; Deng WG
    Oncotarget; 2016 Aug; 7(33):52870-52887. PubMed ID: 27153563
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.
    Sun LL; Wu JY; Wu ZY; Shen JH; Xu XE; Chen B; Wang SH; Li EM; Xu LY
    Int J Cancer; 2015 Mar; 136(6):E569-77. PubMed ID: 25220908
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Alterations in the expression of p53, klf4, and p21 in neuroendocrine lung tumors.
    Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
    Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Correlation of klf4 and SPARC expression with the clinical characteristics of non-small cell lung cancer].
    Zhang Z; Wang Z; Liu X; Shi M; Chen G; Zhang B; Li Z; Song L
    Zhongguo Fei Ai Za Zhi; 2012 Dec; 15(12):720-4. PubMed ID: 23249717
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.